d-609 and Lymphoma

Both Fas and PMA can activate phospholipase D via activation of protein kinase Cbeta in A20 cells. Phospholipase D activity was increased 4 fold in the presence of Fas and 2.5 fold in the presence of PMA. The possible involvement of tyrosine phosphorylation in Fas-induced activation of phospholipase D was investigated. In five minute after Fas cross-linking, there was a prominent increase in tyrosine phosphorylated proteins, and it was completely inhibited by D609, a specific inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC). A tyrosine kinase inhibitor, genistein, can partially inhibit Fas-induced phospholipase D activation. There were no effects of genistein on Fas-induced activation of PC-PLC and protein kinase C. These results strongly indicate that tyrosine phosphorylation may in part account for the increase in phospholipase D activity by Fas cross-linking and D609 can block not only PC-PLC activity but also tyrosine phosphorylation involved in Fas-induced phospholipase D activation.

Topics: Animals; Antibodies, Monoclonal; Bridged-Ring Compounds; Cell Line; Cross-Linking Reagents; Dose-Response Relationship, Immunologic; Enzyme Activation; fas Receptor; Genistein; Hydrolysis; Lymphoma; Mice; Norbornanes; Phospholipase D; Phosphorylation; Phosphorylcholine; Solubility; Thiocarbamates; Thiones; Tumor Cells, Cultured; Type C Phospholipases; Tyrosine; Water